Literature DB >> 12763066

Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons.

J G Minnis1, S Patierno, S E Kohlmeier, N C Brecha, M Tonini, C Sternini.   

Abstract

Immunohistochemistry and confocal microscopy were used to investigate endocytosis and recycling of the native mu opioid receptor (muOR) in enteric neurons. Isolated segments of the guinea-pig ileum were exposed to increasing concentrations of muOR agonists at 4 degrees C to allow ligand binding and warming to 37 degrees C for 0 min (baseline) to 6 h in ligand-free medium to allow receptor internalization and recycling. The endogenous ligand, [Met]enkephalin, and [D-Ala(2),MePhe(4),Gly-ol(5)] enkephalin (DAMGO), an opioid analog, and the alkaloids, etorphine and fentanyl, induced rapid internalization of muOR immunoreactivity in enteric neurons, whereas morphine did not. muOR internalization was prevented by muOR antagonists. Basal levels of muOR immunoreactivity in the cytoplasm were 10.52+/-2.05%. DAMGO (1 nM-100 microM) induced a concentration-dependent increase of muOR immunofluorescence density in the cytoplasm to a maximum of 84.37+/-2.26%. Translocation of muOR immunoreactivity in the cytoplasm was detected at 2 min, reached the maximum at 15-30 min, remained at similar levels for 2 h, began decreasing at 4 h, and was at baseline values at 6 h. A second exposure to DAMGO (100 nM) following recovery of internalized muOR immunoreactivity at the cell surface induced a translocation of muOR immunoreactivity in the cytoplasm comparable to the one observed following the first exposure (46.89+/-3.11% versus 43.31+/-3.80%). muOR internalization was prevented by hyperosmolar sucrose, phenylarsine oxide or potassium depletion, which inhibit clathrin-mediated endocytosis. muOR recycling was prevented by pre-treatment with bafilomycin A1, an acidotropic agent that inhibits endosomal acidification, but not by the protein synthesis inhibitor, cycloheximide. This study shows that native muOR in enteric neurons undergoes ligand-selective endocytosis, which is primarily clathrin-mediated, and recycles following endosomal acidification. Following recycling, muOR is activated and internalized by DAMGO indicating that recycled receptors are functional.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763066     DOI: 10.1016/s0306-4522(03)00135-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.

Authors:  Erica J Melief; Mayumi Miyatake; Michael R Bruchas; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

2.  Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts.

Authors:  Yu Qiu; Yan Wang; Ping-Yee Law; Hong-Zhuan Chen; Horace H Loh
Journal:  Mol Pharmacol       Date:  2011-04-25       Impact factor: 4.436

3.  Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.

Authors:  Johan Enquist; Madeline Ferwerda; Laura Milan-Lobo; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-11-07       Impact factor: 4.030

Review 4.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

5.  Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.

Authors:  Simona Patierno; Laura Anselmi; Ingrid Jaramillo; David Scott; Rachel Garcia; Catia Sternini
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

6.  beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids.

Authors:  Amyaouch Bradaïa; Frédérique Berton; Serge Ferrari; Christian Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-17       Impact factor: 11.205

7.  Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.

Authors:  Minoru Narita; Satoshi Imai; Atsushi Nakamura; Ayumi Ozeki; Megumi Asato; Mahardian Rahmadi; Yuka Sudo; Minoru Hojo; Yasuhito Uezono; Lakshmi A Devi; Naoko Kuzumaki; Tsutomu Suzuki
Journal:  Addict Biol       Date:  2011-08-04       Impact factor: 4.280

8.  Agonist-selective dynamic compartmentalization of human Mu opioid receptor as revealed by resolutive FRAP analysis.

Authors:  Aude Saulière-Nzeh Ndong; Aude Ndong Saulière-Nzeh; Claire Millot; Maithé Corbani; Serge Mazères; André Lopez; Laurence Salomé
Journal:  J Biol Chem       Date:  2010-03-02       Impact factor: 5.157

9.  Glucose-dependent trafficking of 5-HT3 receptors in rat gastrointestinal vagal afferent neurons.

Authors:  T Babic; A E Troy; S R Fortna; K N Browning
Journal:  Neurogastroenterol Motil       Date:  2012-07-30       Impact factor: 3.598

10.  Development of a novel mouse constipation model.

Authors:  Chao Liang; Kai-Yue Wang; Zhi Yu; Bin Xu
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.